Epileptic seizures are one of the more frequently overlooked comorbidities in multiple sclerosis (MS). Recent studies have shown that the rate of epilepsy among MS patients is about twice as high, suggesting that the inflammatory and demyelination processes of MS itself promote epileptogenic mechanisms.
Autoren
- Tanja Schliebe
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- From symptom to diagnosis
Oncology – Thymoma
- Shared decision making
Participatory decision-making using the example of diets for type 1 diabetes
- Patient-centered rounds in medicine
Aligning care with the patient
- Migraine and vascular regulation
CGRP-targeted migraine therapies for vascular risk patients
- Chronic and acute coronary syndrome
Proactive and evidence-based decision-making
- Pediatric multiple sclerosis
Early high efficacy as the key to improving prognosis
- Vaccinations against viral respiratory infections
Influenza, Covid-19 and RSV – Update 2025
- Case report, molecular basis and therapeutic implications